Ergoferon and Oseltamivir in Treatment of Influenza: Results of Multicentre Randomized Comparative Clinical Trial

Ergoferon and Oseltamivir in Treatment of Influenza: Results of Multicentre Randomized Comparative Clinical Trial

The narrow range of choice and virus resistance to the most common drugs require search and introduction of new drugs with proven efficacy and safety for the treatment of influenza. Ergoferon is a new combined medicine containing release active antibodies to interferon-γ (anti-IFNγ), CD4-coreceptor...

Full description

Saved in:
Bibliographic Details
Main Authors: A. V. Averyanov, A. P. Babkin, B. Ya. Bart, A. L. Volchetsky, E. S. Minina, O. A. Kozyrev, M. P. Kostinov, D. V. Petrov, E. P. Selkova, M. A. Putilovsky, V. B. Nechaev, O. I. Epstein, E. N. Andrianova
Format: Article
Language:Russian
Published: LLC "Publishing House OKI" 2020-05-01
Series:Антибиотики и Химиотерапия
Subjects:
influenza
antiviral drugs
fever
ergoferon
release active antibodies
Online Access:https://www.antibiotics-chemotherapy.ru/jour/article/view/445
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items